US Emerging Portfolio Strategy Director

About Servier 

Servier in the U.S. is a Boston-based, commercial-stage biopharmaceutical company launched by Servier Group in 2018. As a privately held organization, Servier is uniquely positioned to advance cutting-edge science, tackle underserved therapeutic areas and make patients the focus of every strategic decision.

Role Summary 

The Director, US Emerging Portfolio Strategy (US EPS) Neurology and reports to Executive Director of US EPS, who has responsibility for assessment of the developing pipeline and external (BD) opportunities in neurology within the US EPS and Corporate Business Office (CBO) team.

The Director US Emerging Portfolio Strategy will be responsible for helping to ensure that the business is best positioned to deliver on its strategy and business priorities for emerging neurology products and lifecycle management programs. This person will lead collaboratively through influence and direct, as appropriate, cross-functional project teams and be a trusted advisor/leader.

Primary Responsibilities

Conduct US Emerging Portfolio Assessments in Neurology

• Support or lead US new product planning projects pre-commercialization – projects may range from preclinical to Phase 3
• In support of business development activities, may support assessment process for all external in-line and pipeline opportunities for all phases
• Contribute to the development of forward-looking strategies, market positioning and product profiles for pipeline/LCM/external opportunity products by synthesizing primary and secondary inputs that will inform the development and lifecycle plan of products / assets
  1. Collaborate with global teams to provide strategic US market insights (e.g. unmet needs, customer segmentation and insights, target product profile input, market potential, US competitive landscape considerations and risks)
  2. Create or support the market entry plan for potential new assets
  3. Proactively incorporate key market developments (both scientific and commercial) and changes in competitive landscape for key therapeutic areas/markets into assessment updates
• Incorporate pipeline/LCM strategy in the medium to long term US strategic plans

Contributes to CBO Team Success

• Contributes to success of the CBO team by sharing best practices with other CBO members and support team offsites, events, developing and tracking annual team goals and budgets
• Coordinates with Emerging Portfolio Leader to share learnings and raise the bar for the group and organization
• Supports identification of opportunities for improved team effectiveness and collaboration, being an active contributor to the collaborative and transparent team culture